» Articles » PMID: 25431601

A Comparative View on Human Somatic Cell Sources for IPSC Generation

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2014 Nov 29
PMID 25431601
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

The breakthrough of reprogramming human somatic cells was achieved in 2006 by the work of Yamanaka and Takahashi. From this point, fibroblasts are the most commonly used primary somatic cell type for the generation of induced pluripotent stem cells (iPSCs). Various characteristics of fibroblasts supported their utilization for the groundbreaking experiments of iPSC generation. One major advantage is the high availability of fibroblasts which can be easily isolated from skin biopsies. Furthermore, their cultivation, propagation, and cryoconservation properties are uncomplicated with respect to nutritional requirements and viability in culture. However, the required skin biopsy remains an invasive approach, representing a major drawback for using fibroblasts as the starting material. More and more studies appeared over the last years, describing the reprogramming of other human somatic cell types. Cells isolated from blood samples or urine, as well as more unexpected cell types, like pancreatic islet beta cells, synovial cells, or mesenchymal stromal cells from wisdom teeth, show promising characteristics for a reprogramming strategy. Here, we want to highlight the advantages of keratinocytes from human plucked hair as a widely usable, noninvasive harvesting method for primary material in comparison with other commonly used cell types.

Citing Articles

Inhibition of TGF-β signaling enhances osteogenic potential of iPSC-derived MSCs.

Umrath F, Frick S, Wendt V, Naros A, Zimmerer R, Alexander D Sci Rep. 2025; 15(1):7814.

PMID: 40050624 PMC: 11885616. DOI: 10.1038/s41598-025-89370-w.


Human iPSC Reprogramming Success: The Impact of Approaches and Source Materials.

Pozner T, Grandizio C, Mitchell M, Turan N, Scheinfeldt L Stem Cells Int. 2025; 2025:2223645.

PMID: 39850337 PMC: 11756937. DOI: 10.1155/sci/2223645.


Generation of Retinal Ganglion Cells from Reprogrammed Keratocytes of Non-Glaucoma and Glaucoma Donors.

Hameed S, Sharma T Curr Protoc. 2025; 5(1):e70091.

PMID: 39781605 PMC: 11713219. DOI: 10.1002/cpz1.70091.


Integration and Differentiation of Transplanted Human iPSC-Derived Retinal Ganglion Cell Precursors in Murine Retinas.

Lei Q, Zhang R, Yuan F, Xiang M Int J Mol Sci. 2024; 25(23).

PMID: 39684658 PMC: 11641514. DOI: 10.3390/ijms252312947.


Efficient generation of human induced pluripotent stem cells from urine samples of patients with Fragile X syndrome.

Dionne O, Sabatie S, Fortin F, Corbin F, Laurent B Front Cell Dev Biol. 2024; 12:1489190.

PMID: 39650724 PMC: 11621072. DOI: 10.3389/fcell.2024.1489190.


References
1.
Merling R, Sweeney C, Choi U, de Ravin S, Myers T, Otaizo-Carrasquero F . Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood. 2013; 121(14):e98-107. PMC: 3617640. DOI: 10.1182/blood-2012-03-420273. View

2.
Paus R, Foitzik K . In search of the "hair cycle clock": a guided tour. Differentiation. 2004; 72(9-10):489-511. DOI: 10.1111/j.1432-0436.2004.07209004.x. View

3.
Serwold T, Hochedlinger K, Inlay M, Jaenisch R, Weissman I . Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes. J Immunol. 2007; 179(2):928-38. DOI: 10.4049/jimmunol.179.2.928. View

4.
Reinhardt P, Schmid B, Burbulla L, Schondorf D, Wagner L, Glatza M . Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell. 2013; 12(3):354-67. DOI: 10.1016/j.stem.2013.01.008. View

5.
Warlich E, Kuehle J, Cantz T, Brugman M, Maetzig T, Galla M . Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol Ther. 2011; 19(4):782-9. PMC: 3070104. DOI: 10.1038/mt.2010.314. View